The activation of immunoglobulin G Fc receptors (FcγRs) with immunoreceptor tyrosine-based activation motifs (ITAMs) promotes cognitive impairment in aged rats with diabetes
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved..
AIMS: Although immunoglobulin G Fc receptors with immunoreceptor tyrosine-based activation motifs (ITAM-FcγRs) have been implicated in the mediation of inflammatory responses, the importance of these receptors in the pathogenesis of cognitive impairment in geriatric diabetes remains unclear. The present study investigated the potential role of ITAM-FcγRs in cognitive impairment in geriatric diabetes.
METHODS: Diabetes was induced by streptozotocin (STZ) in aged Wistar rats, and cognitive function and cerebral injury were assessed 8 weeks later using the Morris water maze (MWM), real-time PCR and Western blot. In vitro, the inhibition of ITAM-FcγRs was investigated using rat chromaffin cells cultured with high glucose.
RESULTS: Aged rats with diabetes exhibited marked and persistent learning and memory impairments. Enhanced cerebral inflammation in the diabetic aged rats was associated with the overactivation of the nuclear factor κB (NF-κB) signaling pathway and the upregulation of inflammatory cytokines (interleukin-6 (IL-6) and tumor nuclear factor-α (TNF-α)) in the hippocampus. Compared to no treatment, the knockdown of FcγRIV (the main isoform of ITAM-FcγRs) markedly attenuated cognitive impairment as well as histologic and ultrastructural pathologic changes in the diabetic rats. The increased expression of inflammatory cytokines and the overactivation of the NF-κB signaling pathway were also significantly alleviated. In vitro, high glucose concentrations significantly activated the NF-κB signaling pathway and increased the expression of inflammatory cytokines. The inhibition of FcγR expression by a small interfering RNA and/or a FcγRI- and FcγRIII-neutralizing antibody significantly ameliorated the effects mediated by high glucose.
CONCLUSION: The enhanced activation of the NF-κB signalling pathway may be the mechanism by which ITAM-FcγRs promote cerebral inflammation and cognitive impairment in diabetes. ITAM-FcγRs may be viewed as a potential target for preventative intervention for cognitive impairment in older adults with diabetes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:125 |
---|---|
Enthalten in: |
Experimental gerontology - 125(2019) vom: 01. Okt., Seite 110660 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Yue, Qiang [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 16.07.2020 Date Revised 16.07.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.exger.2019.110660 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM299316432 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM299316432 | ||
003 | DE-627 | ||
005 | 20231225100052.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.exger.2019.110660 |2 doi | |
028 | 5 | 2 | |a pubmed24n0997.xml |
035 | |a (DE-627)NLM299316432 | ||
035 | |a (NLM)31319129 | ||
035 | |a (PII)S0531-5565(18)30195-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Yue, Qiang |e verfasserin |4 aut | |
245 | 1 | 4 | |a The activation of immunoglobulin G Fc receptors (FcγRs) with immunoreceptor tyrosine-based activation motifs (ITAMs) promotes cognitive impairment in aged rats with diabetes |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.07.2020 | ||
500 | |a Date Revised 16.07.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a AIMS: Although immunoglobulin G Fc receptors with immunoreceptor tyrosine-based activation motifs (ITAM-FcγRs) have been implicated in the mediation of inflammatory responses, the importance of these receptors in the pathogenesis of cognitive impairment in geriatric diabetes remains unclear. The present study investigated the potential role of ITAM-FcγRs in cognitive impairment in geriatric diabetes | ||
520 | |a METHODS: Diabetes was induced by streptozotocin (STZ) in aged Wistar rats, and cognitive function and cerebral injury were assessed 8 weeks later using the Morris water maze (MWM), real-time PCR and Western blot. In vitro, the inhibition of ITAM-FcγRs was investigated using rat chromaffin cells cultured with high glucose | ||
520 | |a RESULTS: Aged rats with diabetes exhibited marked and persistent learning and memory impairments. Enhanced cerebral inflammation in the diabetic aged rats was associated with the overactivation of the nuclear factor κB (NF-κB) signaling pathway and the upregulation of inflammatory cytokines (interleukin-6 (IL-6) and tumor nuclear factor-α (TNF-α)) in the hippocampus. Compared to no treatment, the knockdown of FcγRIV (the main isoform of ITAM-FcγRs) markedly attenuated cognitive impairment as well as histologic and ultrastructural pathologic changes in the diabetic rats. The increased expression of inflammatory cytokines and the overactivation of the NF-κB signaling pathway were also significantly alleviated. In vitro, high glucose concentrations significantly activated the NF-κB signaling pathway and increased the expression of inflammatory cytokines. The inhibition of FcγR expression by a small interfering RNA and/or a FcγRI- and FcγRIII-neutralizing antibody significantly ameliorated the effects mediated by high glucose | ||
520 | |a CONCLUSION: The enhanced activation of the NF-κB signalling pathway may be the mechanism by which ITAM-FcγRs promote cerebral inflammation and cognitive impairment in diabetes. ITAM-FcγRs may be viewed as a potential target for preventative intervention for cognitive impairment in older adults with diabetes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Cognitive impairment | |
650 | 4 | |a Diabetes mellitus (DM) | |
650 | 4 | |a Immunoglobulin G Fc receptors (FcγRs) | |
650 | 4 | |a Immunoreceptor tyrosine-based activation motif (ITAM) | |
650 | 7 | |a Interleukin-6 |2 NLM | |
650 | 7 | |a NF-kappa B |2 NLM | |
650 | 7 | |a Receptors, IgG |2 NLM | |
650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
650 | 7 | |a interleukin-6, mouse |2 NLM | |
700 | 1 | |a Meng, Zhangmin |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lingxiao |e verfasserin |4 aut | |
700 | 1 | |a Sun, Qianqian |e verfasserin |4 aut | |
700 | 1 | |a Wang, Shuang |e verfasserin |4 aut | |
700 | 1 | |a Li, Jun |e verfasserin |4 aut | |
700 | 1 | |a Liu, Fei |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Experimental gerontology |d 1968 |g 125(2019) vom: 01. Okt., Seite 110660 |w (DE-627)NLM000016608 |x 1873-6815 |7 nnns |
773 | 1 | 8 | |g volume:125 |g year:2019 |g day:01 |g month:10 |g pages:110660 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.exger.2019.110660 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 125 |j 2019 |b 01 |c 10 |h 110660 |